Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LUC7-Like (LUC7L) (N-Term) Peptide

LUC7L Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN8104590
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour LUC7-Like (LUC7L) (N-Term) Peptide (ABIN8104590)

Antigène

LUC7L (LUC7-Like (LUC7L))

Origine

Humain

Source

  • 7
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Fonction

    LUC7L Peptide - N-terminal region

    Séquence

    YEIASKERDL FFELDAMDHL ESFIAECDRR TELAKKRLAE TQEEISAEVS
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-LUC7L Antibody(ARP57815_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    LUC7L (LUC7-Like (LUC7L))

    Sujet

    Background Information: The LUC7L gene may represent a mammalian heterochromatic gene, encoding a putative RNA-binding protein similar to the yeast Luc7p subunit of the U1 snRNP splicing complex that is normally required for 5-prime splice site selection (Tufarelli et al., 2001 [PubMed 11170747]).

    Alternative Symbols: FLJ10231, LUC7-LIKE, LUC7B1, SR+89, Luc7, hLuc7B1

    Poids moléculaire

    44kDa

    ID gène

    55692

    NCBI Accession

    NP_958815

    UniProt

    Q9NQ29
Vous êtes ici:
Chat with us!